Laser plus two drops may beat standard care for glaucoma
NCT ID NCT07465913
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a combination of two eye drops (netarsudil and latanoprost) after laser treatment works better than adding just one drop (latanoprost) for lowering eye pressure in people with glaucoma. About 36 adults with mild to moderate glaucoma will take part. The goal is to find the most effective way to manage eye pressure after laser therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eye Centers of Southeast Texas
RECRUITINGBeaumont, Texas, 77707, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Could your personality predict glaucoma drug side effects?
- Could a single eye implant replace years of glaucoma drops?